Experimental cholesterol drugs could reduce heart risk
SAN DIEGO - New research is boosting hope that a highly anticipated, experimental class of cholesterol drugs can greatly lower the risk for heart attacks, death and other heart-related problems.
Studies presented at a cardiology conference in San Diego today suggest that people taking one of these drugs had half the risk of dying or suffering a heart problem compared to others who were given the usual care.
However, side effects remain a question. The Food and Drug Administration will decide this summer whether to allow the drugs on the market.